L22 ribosomal protein is involved in dynamin-related protein 1-mediated gastric carcinoma progression

References

• Strong VE. Progress in gastric cancer. Updates Surg. 2018;70(2):157–159.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep. 2019;21(8):67.
   PubMed Web of Science ®Google Scholar
• Yao SW, Yang W. Overexpression of Mst1 reduces gastric cancer cell viability by repressing the AMPK-Sirt3 pathway and activating mitochondrial fission. Vol. 11. Oncotargets and Therapy; 2018. p. 8465–8479.
   Google Scholar
• Grandemange S, Herzig S, Martinou J-C. Mitochondrial dynamics and cancer. Semin Cancer Biol. 2009;19(1):50–56.
   PubMed Web of Science ®Google Scholar
• Hu C, Huang Y, Li L. Drp1-dependent mitochondrial fission plays critical roles in physiological and pathological progresses in mammals. Int J Mol Sci. 2017;18(1):144.
   PubMed Web of Science ®Google Scholar
• Inoue-Yamauchi A, Oda H. Depletion of mitochondrial fission factor DRP1 causes increased apoptosis in human colon cancer cells. Biochem Biophys Res Commun. 2012;421(1):81–85.
   PubMed Web of Science ®Google Scholar
• Zhan L, Cao HY, Wang G, et al. Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-kappa B pathways in hepatocellular carcinoma. Oncotarget. 2016;7(40):65001–65011.
   PubMedGoogle Scholar
• Qian W, Wang JN, Van Houten B. The role of dynamin-related protein 1 in cancer growth: a promising therapeutic target? Expert Opin Ther Targets. 2013;17(9):997–1001.
   PubMed Web of Science ®Google Scholar
• Lima AR, Santos L, Correia M, et al. Dynamin-related protein 1 at the crossroads of cancer. Genes (Basel). 2018;9(2):115.
   PubMed Web of Science ®Google Scholar
• Rehman J, Zhang HJ, Toth PT, et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J. 2012;26(5):2175–2186.
   PubMed Web of Science ®Google Scholar
• Aung LHH, Li RB, Prabhakar BS, et al. Mitochondrial protein 18 (MTP18) plays a pro-apoptotic role in chemotherapy-induced gastric cancer cell apoptosis. Oncotarget. 2017;8(34):56582–56597.
   PubMedGoogle Scholar
• Kim HJ, Maiti P, Barrientos A. Mitochondrial ribosomes in cancer. Semin Cancer Biol. 2017;47:67–81.
   PubMed Web of Science ®Google Scholar
• De Silva D, Tu YT, Amunts A, et al. Mitochondrial ribosome assembly in health and disease. Cell Cycle. 2015;14(14):2226–2250.
   PubMed Web of Science ®Google Scholar
• Koc EC, Ranasinghe A, Burkhart W, et al. A new face on apoptosis: death-associated protein 3 and PDCD9 are mitochondrial ribosomal proteins. FEBS Lett. 2001;492(1–2):166-+.
   PubMed Web of Science ®Google Scholar
• Sugimoto T, Seki N, Shimizu S, et al. The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma. Genes Chromosomes & Cancer. 2009;48(2):132–142.
   PubMed Web of Science ®Google Scholar
• Koc EC, Haciosmanoglu E, Claudio PP, et al., Impaired mitochondrial protein synthesis in head and neck squamous cell carcinoma. Mitochondrion, 2015. 24: p. 113–121.
   Google Scholar
• Shi Y, Zhai H, Wang X, et al. Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis. Exp Cell Res. 2004;296(2):337–346.
   PubMed Web of Science ®Google Scholar
• Fahl SP, Wang M, Zhang Y, et al. Regulatory roles of Rpl22 in hematopoiesis: an old dog with new tricks. Crit Rev Immunol. 2015;35(5):379–400.
   PubMed Web of Science ®Google Scholar
• Zhang Y, O’Leary MN, Peri S, et al. Ribosomal proteins Rpl22 and Rpl22l1 control morphogenesis by regulating pre-mRNA splicing. Cell Rep. 2017;18(2):545–556.
   PubMed Web of Science ®Google Scholar
• Sun Z, Qiu Z, Wang Z, et al. Silencing ribosomal protein L22 promotes proliferation and migration, and inhibits apoptosis of gastric cancer cells by regulating the murine double minute 2-protein 53 (MDM2-p53) signaling pathway. Med Sci Monit. 2021;27:e928375.
   PubMed Web of Science ®Google Scholar
• Tang ZF, Li CW, Kang BX, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-seq data. Nucleic Acids Res. 2014;42(D1):D92–D97.
   PubMed Web of Science ®Google Scholar
• Seo JH, Chae YC, Kossenkov AV, et al. MFF regulation of mitochondrial cell death is a therapeutic target in cancer. Cancer Res. 2019;79(24):6215–6226.
   PubMed Web of Science ®Google Scholar
• Passaniti A, Hussain A. Novel approaches targeting mitochondrial fission to deplete stem-like tumor cells in prostate cancer and improve treatment outcomes. Ann Transl Med. 2019;7(1):7.
   PubMedGoogle Scholar
• Zhai JW, Wang YC, Yang FS, et al. DRP-1, ezrin and E-cadherin expression and the association with esophageal squamous cell carcinoma. Oncol Lett. 2014;8(1):133–138.
   PubMed Web of Science ®Google Scholar
• Milani M, Byrne DP, and Greaves G, et al. DRP-1 is required for BH3 mimetic-mediated mitochondrial fragmentation and apoptosis . Cell Death & Disease; 2017. 8(1):e2552.
   Google Scholar
• Wang JX, Li Q, Li PF. Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1. Cancer Res. 2009;69(2):492–500.
   PubMed Web of Science ®Google Scholar
• Yu LL, Xiao ZK, Tu HY, et al. The expression and prognostic significance of Drp1 in lung cancer A bioinformatics analysis and immunohistochemistry. Medicine (Baltimore). 2019;98(48):e18228.
   PubMed Web of Science ®Google Scholar
• Huang CY, Chiang SF, and Chen WTL, et al. HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer. Cell Death & Disease; 2018. 9(1):1004.
   Google Scholar
• Dai WT, Jiang L, Huang Z. Dysregulated mitochondrial dynamics and metabolism in obesity, diabetes, and cancer. Front Endocrinol (Lausanne). 2019;10:10.
   PubMed Web of Science ®Google Scholar
• Wu DC, Dasgupta A, Chen KH, et al. Identification of novel dynamin-related protein 1 (Drp1) GTPase inhibitors: therapeutic potential of drpitor1 and drpitor1a in cancer and cardiac ischemia-reperfusion injury. FASEB J. 2020;34(1):1447–1464.
   PubMed Web of Science ®Google Scholar
• Tusskorn O, Khunluck T, Prawan A, et al. Mitochondrial division inhibitor-1 potentiates cisplatin-induced apoptosis via the mitochondrial death pathway in cholangiocarcinoma cells. Biomed Pharmacother. 2019;111:109–118.
   PubMed Web of Science ®Google Scholar
• Dai WT, Wang G, Chwa J, et al. Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer. Br J Cancer. 2020;122(9):1288–1297.
   PubMed Web of Science ®Google Scholar
• Wang JN, Li JF, Santana-Santos L, et al. A novel strategy for targeted killing of tumor cells: induction of multipolar acentrosomal mitotic spindles with a quinazolinone derivative mdivi-1. Mol Oncol. 2015;9(2):488–502.
   PubMed Web of Science ®Google Scholar
• Wu P, Li Y, Zhu S, et al. Mdivi-1 alleviates early brain injury after experimental subarachnoid hemorrhage in rats, possibly via inhibition of Drp1-activated mitochondrial fission and oxidative stress. Neurochem Res. 2017;42(5):1449–1458.
   PubMed Web of Science ®Google Scholar
• Yang MX, Sun HB, He J, et al. Interaction of ribosomal protein L22 with casein kinase 2 alpha: a novel mechanism for understanding the biology of non-small cell lung cancer. Oncol Rep. 2014;32(1):139–144.
   PubMed Web of Science ®Google Scholar
• Yang MX, Sun HB, Wang H, et al. Down-regulation of ribosomal protein L22 in non-small cell lung cancer. Med Oncol. 2013;30(3). DOI:10.1007/s12032-013-0646-0
   Web of Science ®Google Scholar
• Li J, Hou YL, Ding X, et al. Overexpression, purification, molecular characterization and the effect on tumor growth of ribosomal protein L22 from the giant panda (Ailuropoda melanoleuca). Mol Biol Rep. 2014;41(5):3529–3539.
   PubMed Web of Science ®Google Scholar
• Kaushal PS, Sharma MR, Booth TM, et al. Cryo-EM structure of the small subunit of the mammalian mitochondrial ribosome. Proc Natl Acad Sci U S A. 2014;111(20):7284–7289.
   PubMed Web of Science ®Google Scholar
• Koc EC, Burkhart W, Blackburn K, et al. The large subunit of the mammalian mitochondrial ribosome - analysis of the complement of ribosomal proteins present. J Biol Chem. 2001;276(47):43958–43969.
   PubMed Web of Science ®Google Scholar
• Li H-B, Wang R-X, Jiang H-B, et al. Mitochondrial ribosomal protein L10 associates with cyclin B1/Cdk1 activity and mitochondrial function. DNA Cell Biol. 2016;35(11):680–690.
   PubMed Web of Science ®Google Scholar